肿瘤资讯系统市场 - 全球产业规模、份额、趋势、机会及预测（按产品/服务、应用、最终用户、地区和竞争格局划分），2021-2031年

全球肿瘤资讯系统市场预计将从 2025 年的 98.6 亿美元成长到 2031 年的 154.6 亿美元，复合年增长率为 7.78%。

这些专业软体平台旨在全面管理与癌症治疗相关的整体临床、行政和财务数据，从而实现肿瘤内科和放射肿瘤科之间的无缝工作流程。市场的主要驱动因素包括迫切需要整合分散的病患记录，以及电子健康记录的日益普及，以促进精准的治疗计画。因此，面对日益加重的全球疾病负担，这些系统对于最大限度地提高临床效率和确保符合实证医学标准至关重要。

然而，实施这些系统的高昂成本对市场成长构成重大障碍，尤其对于那些难以承担巨额初始投资的小规模医疗中心而言更是如此。此外，各种数位系统之间缺乏互通性也常常阻碍必要的医疗数据共用。这类综合管理解决方案的需求源自于癌症发生率的不断上升。美国癌症协会预测，到2025年，美国将新增约2,041,910例癌症病例，凸显了医疗服务提供者必须有效处理大量病患资讯的重要性。

市场驱动因素

人工智慧 (AI) 和机器学习在治疗计划中的应用正对全球肿瘤资讯系统市场产生变革性影响，显着改变临床操作和决策策略。这些先进的演算法工具正逐步整合到肿瘤系统中，以实现器官分割和剂量优化等复杂流程的自动化，从而提高准确性并减轻临床团队的行政负担。随着医疗机构寻求应对日益复杂的癌症管理，这些智慧辅助系统的应用正在加速发展。 OncLive 在 2025 年 1 月发表的一篇题为《调查结果：人工智慧不会退出肿瘤领域，但其有效性仍令人担忧》的报导中强调了这一转变。报导指出，26.7% 的受访肿瘤科医师目前使用人工智慧工具辅助治疗决策，显示自动化辅助已成为显着趋势。

同时，政府对癌症研究的支持和投入不断增加，为实施这些先进的数位基础设施奠定了必要的财政基础。公共部门的投资对于医疗设施现代化、集中管理患者记录以及实施符合价值医疗策略的整合系统至关重要。这项承诺也体现在近期的政策措施中。例如，英国政府在2025年5月于GOV.UK网站发布的题为「政府技术改革助力癌症诊断转型」的新闻稿中承诺设立10亿英镑的专款，用于数位转型。这项财政支持不仅加速了系统的应用，也刺激了市场动态。这一趋势同样体现在私部门。西门子医疗在2024年11月发布的「2024年第四季财务表现」中预测，其2025年的销售额将年增5-6%。这主要得益于市场对尖端肿瘤技术的持续需求。

市场挑战

高昂的实施成本是全球肿瘤资讯系统市场扩张的主要障碍。实施一套全面的肿瘤平台需要大量的资本支出，包括软体采购、硬体整合和专业人员培训，这构成了很高的进入门槛。对于不具备大规模学术医疗中心雄厚资源的中小型医疗机构和私人诊所而言，这种财务负担尤其沉重。因此，这些小规模的机构往往会延后采用必要的数位化管理工具，这直接抑制了整体市场需求，并减缓了整个产业的技术普及。

不断上涨的营运成本与停滞不前的报销率之间的巨大差距，进一步加剧了这些财务困境。根据美国医院协会 (AHA) 2025 年的数据，2022 年至 2024 年间，整体通货膨胀率上涨了 14.1%，而联邦医疗保险 (Medicare) 的住院支付率仅上涨了 5.1%。这种经济差距严重限制了医疗服务提供者可支配的财务资源。面对利润率的下降，各机构被迫优先考虑眼前的患者照护成本，而非投资新的IT基础设施，阻碍了肿瘤资讯系统市场的整体成长。

市场趋势

云端和SaaS肿瘤资讯系统（OIS）平台的广泛应用正在改变癌症诊疗模式，以灵活的Web架构取代了传统的本地伺服器。这些创新使多学科团队能够随时随地安全地存取关键的患者资讯和治疗方案，支援复杂肿瘤会诊所需的远端协作，同时显着降低本地硬体维护成本。这种向灵活软体环境的转变是市场活动的关键驱动因素。例如，RaySearch Laboratories在其2025年11月发布的「2025财年第三季中期报告」中指出，其净销售额年增13%至3.32亿瑞典克朗，并将这一增长主要归功于市场对其肿瘤资讯系统和规划软体RayCare的强劲需求。

将基因组数据整合到精准肿瘤学工作流程中，正迫使肿瘤免疫系统（OIS）提供者更新其係统，以便在标准临床记录之外管理复杂的分子图谱。随着治疗越来越侧重于基因突变，肿瘤平台必须能够直接导入、储存和显示次世代定序数据，以支持治疗决策。这项功能使临床医生无需离开其主要工作区，即可有效地将具有特定生物标记的患者与合适的免疫疗法进行配对。 Guardant Health 在 2025 年 12 月发布的题为「Guardant Health 宣布与 Trial Library 合作」的新闻稿中揭示了这种数据利用的规模。该公司透露，它正在利用大规模真实世界数据平台，以增强对合格精准医疗试验条件的候选人的识别。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球肿瘤资讯系统市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品/服务（软体、专业服务）分类
  • 依应用领域（放射肿瘤学、内科肿瘤学、外科肿瘤学）
  • 依最终使用者（医院/肿瘤诊所、研究中心、其他）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美肿瘤资讯系统市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲肿瘤资讯系统市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区肿瘤资讯系统市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲肿瘤资讯系统市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10. 南美洲肿瘤资讯系统市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球肿瘤资讯系统市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Elekta AB
• Varian Medical Systems, Inc.
• Epic Systems Corporation
• Philips Healthcare
• Cerner Corporation
• IBM Corporation
• Siemens Healthineers
• RaySearch Laboratories AB
• Koninklijke Philips NV
• McKesson Corporation

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Oncology Information System Market is anticipated to expand from USD 9.86 Billion in 2025 to USD 15.46 Billion by 2031, reflecting a compound annual growth rate of 7.78%. These specialized software platforms are engineered to oversee the full spectrum of clinical, administrative, and financial data related to cancer treatment, enabling seamless workflows across medical and radiation oncology. Key market drivers include the urgent need to consolidate scattered patient records and the growing incorporation of electronic medical records to facilitate accurate treatment planning. Consequently, these systems are vital for maximizing clinical productivity and ensuring compliance with evidence-based standards in the face of an increasing global disease burden.

However, the high expense associated with deploying these systems poses a major obstacle to market growth, especially for smaller healthcare centers that cannot easily afford the substantial upfront capital required. Furthermore, the lack of interoperability among various digital systems frequently hinders the necessary sharing of medical data. The demand for these comprehensive management solutions is driven by the rising prevalence of cancer; the American Cancer Society projects that there will be approximately 2,041,910 new cancer cases in the United States in 2025, emphasizing the massive volume of patient information that healthcare providers must efficiently handle.

Market Driver

The incorporation of Artificial Intelligence and Machine Learning into treatment planning is emerging as a revolutionary influence in the Global Oncology Information System Market, significantly altering clinical operations and decision-making strategies. These sophisticated algorithmic tools are progressively being integrated into oncology systems to automate intricate processes like organ segmentation and dose optimization, which improves accuracy and lessens the administrative load on clinical teams. As providers attempt to handle the increasing intricacies of cancer management, the uptake of these smart support systems is gaining momentum. This shift is highlighted by data from OncLive in January 2025, which reported in an article titled 'Survey Says: AI Isn't Going Anywhere in Oncology, But Validity Concerns Remain' that 26.7% of surveyed oncologists are now using AI tools for treatment decision support, signaling a major move towards automated assistance.

Simultaneously, rising government support and funding for cancer research are establishing the necessary financial foundation for implementing these advanced digital infrastructures. Public sector investments are essential for updating healthcare facilities, enabling them to acquire integrated systems that centralize patient records and align with value-based care strategies. This dedication is visible in recent policy actions; for instance, the UK government confirmed a £1 billion fund dedicated to digital transformation in a press release titled 'Government's tech reform to transform cancer diagnosis' published on GOV.UK in May 2025. This financial backing not only aids in system adoption but also boosts market dynamics, a trend mirrored in the private sector where Siemens Healthineers, in their 'Q4 Fiscal Year 2024 Financial Results' from November 2024, anticipated comparable revenue growth of 5% to 6% for fiscal year 2025, largely attributed to the ongoing demand for cutting-edge oncology technologies.

Market Challenge

The significant expense required for implementation serves as a major impediment to the expansion of the Global Oncology Information System Market. Deploying comprehensive oncology platforms necessitates a considerable financial outlay for purchasing software, integrating hardware, and training specialized personnel, which establishes a steep barrier to entry. This financial burden is especially difficult for smaller healthcare institutions and independent practices that do not possess the extensive resources found in large academic centers. Consequently, these smaller organizations frequently delay the acquisition of necessary digital management tools, which directly dampens overall market demand and retards the speed of technological adoption throughout the industry.

These financial limitations are further exacerbated by the gap between escalating operational expenses and stagnant reimbursement rates. Data from the American Hospital Association in 2025 indicates that while general inflation surged by 14.1 percent between 2022 and 2024, Medicare inpatient payment rates saw a mere 5.1 percent increase. This economic disparity severely limits the discretionary funds available to healthcare providers. Faced with shrinking margins, organizations are forced to prioritize immediate patient care costs over investments in new IT infrastructure, thereby hindering the broader growth of the oncology information system market.

Market Trends

The broad acceptance of Cloud-Based and SaaS OIS platforms is transforming cancer care by substituting rigid on-premise servers with adaptable, web-enabled architectures. These innovations enable multidisciplinary teams to securely access vital patient information and treatment strategies from any location, supporting the remote collaboration necessary for complex tumor boards while substantially lowering costs associated with local hardware maintenance. This transition towards flexible software environments is a primary driver of market activity; for example, RaySearch Laboratories reported a 13% increase in net sales to SEK 332 million in their 'Interim report third quarter 2025' from November 2025, a growth largely attributed to strong demand for their RayCare oncology information system and planning software.

The integration of genomic data into precision oncology workflows is forcing OIS providers to update their systems to manage intricate molecular profiles alongside standard clinical records. As treatments become increasingly tailored to genetic mutations, oncology platforms are required to ingest, store, and display next-generation sequencing data to directly aid therapeutic decision-making. This capability ensures that clinicians can efficiently match patients exhibiting specific biomarkers with the correct immunotherapies without exiting their primary workspace. The magnitude of this data usage is illustrated by Guardant Health, which, in a December 2025 press release titled 'Guardant Health Announces Collaboration with Trial Library', revealed that it utilizes a vast real-world data platform containing over 1 million tested patients to enhance the identification of suitable candidates for precision medicine trials.

Key Market Players

• Elekta AB
• Varian Medical Systems, Inc.
• Epic Systems Corporation
• Philips Healthcare
• Cerner Corporation
• IBM Corporation
• Siemens Healthineers
• RaySearch Laboratories AB
• Koninklijke Philips N.V.
• McKesson Corporation

Report Scope

In this report, the Global Oncology Information System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Oncology Information System Market, By Product & Services

• Software
• Professional Service

Oncology Information System Market, By Application

• Radiation Oncology
• Medical Oncology
• Surgical Oncology

Oncology Information System Market, By End User

• Hospital & Oncology Clinic
• Research Center
• Others

Oncology Information System Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Oncology Information System Market.

Available Customizations:

Global Oncology Information System Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Oncology Information System Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product & Services (Software, Professional Service)
  • 5.2.2. By Application (Radiation Oncology, Medical Oncology, Surgical Oncology)
  • 5.2.3. By End User (Hospital & Oncology Clinic, Research Center, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Oncology Information System Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product & Services
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Oncology Information System Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product & Services
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Oncology Information System Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product & Services
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Oncology Information System Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product & Services
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Oncology Information System Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product & Services
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Oncology Information System Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product & Services
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. France Oncology Information System Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product & Services
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Oncology Information System Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product & Services
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Oncology Information System Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product & Services
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Oncology Information System Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product & Services
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia Pacific Oncology Information System Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product & Services
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Oncology Information System Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product & Services
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Oncology Information System Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product & Services
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Oncology Information System Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product & Services
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Oncology Information System Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product & Services
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Oncology Information System Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product & Services
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. Middle East & Africa Oncology Information System Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product & Services
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Oncology Information System Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product & Services
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Oncology Information System Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product & Services
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Oncology Information System Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product & Services
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. South America Oncology Information System Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product & Services
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Oncology Information System Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product & Services
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Oncology Information System Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product & Services
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Oncology Information System Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product & Services
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Oncology Information System Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Elekta AB
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Varian Medical Systems, Inc.
• 15.3. Epic Systems Corporation
• 15.4. Philips Healthcare
• 15.5. Cerner Corporation
• 15.6. IBM Corporation
• 15.7. Siemens Healthineers
• 15.8. RaySearch Laboratories AB
• 15.9. Koninklijke Philips N.V.
• 15.10. McKesson Corporation

16. Strategic Recommendations

17. About Us & Disclaimer